Journal of Clinical Medicine· 2026Q2

Herpesviridae Reactivation and Therapeutic Outcomes in Patients with Ulcerative Colitis Treated with Tofacitinib

Sivan Harnik, Naama Lang, Shiran Yehezkel, Ella Fudim et al.

0citations
Q2SCImago
2026year

Short summary

Tofacitinib treatment for ulcerative colitis (UC) led to asymptomatic Herpesviridae (HSV/VZV) reactivation in 33.3% of patients (n=24), with no detected association with clinical disease activity or calprotectin levels.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

GeneticsBiochemistry, Genetics and Molecular Biology